“To see this tournament continue to grow and prosper. It makes you feel good. And it’s because there’s such a good variety of ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

When David Ricks became CEO of Eli Lilly, he faced the usual pressures of making the right, albeit risky, bets on the next big pharmaceutical breakthrough. But he also faced a unique challenge ...

Indiana Gov. Eric Holcomb has appointed David A. Ricks to the Purdue University Board of Trustees, effective Jan. 1, 2025, through June 30, 2027.

For Eli Lilly CEO Dave Ricks, speeding up the drug discovery process is essential to success.

The good news about donanemab, Eli Lilly’s Alzheimer’s drug, reached CEO Dave Ricks on July 2 as he was hiking in a remote part of Colorado. The pharmaceutical company had slogged for 35 years ...

Eli Lilly CEO Dave Ricks made $114 million in 2024, according to a new proxy statement to investors, putting him in the rare company of health care executives who have pulled in at least nine ...

The David Rubenstein Show: Peer-to-Peer Conversations explores successful leadership through the personal and professional choices of the most influential people in business.

David Ricks and Dr. Fatima Cody Stanford talk through the groundbreaking role of GLP-1 medications in transforming the treatment of obesity, and how they might reshape the future of health care ...

Chief Executive magazine announced April 7 that Dave Ricks, chair and CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year.

On the C-SPAN Networks: David A. Ricks is a President and CEO for the Eli Lilly and Company with four videos in the C-SPAN Video Library; the first appearance was a 2017 Remarks. The year with the ...